Company / Operating Income per Share
Collegium Pharmaceutical, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$5.67
FY2025
5-year range
$0.52 / $5.67
FY2021-FY2025
Trend
+4.8%
vs FY2024
Sector context
#14 of 201
Health Care
What the data says
Among 201 Health Care companies, Collegium Pharmaceutical, Inc. is in the top 7% for operating income per share. Operating Income per Share has increased for 4 consecutive years, from $0.52 in FY2021 to $5.67 in FY2025.
Based on SEC 10-K filings.
5.67 in FY2025 with a 5-year CAGR of +28.4%. Top quartile in the Health Care sector.
Improved from $5.24 to $5.67 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +79.2%
- 5-Year CAGR
- +28.4%
- 10-Year CAGR
- -
Sector benchmark
+119.9% above sector average
Key checks
Key Insights
- Collegium Pharmaceutical, Inc.'s operating income per share has grown for 4 consecutive years.
- In FY2025, operating income per share increased 4.8% year-over-year.
- Ranks #14 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.67 | +4.8% |
| FY2024 | $5.40 | +3.1% |
| FY2023 | $5.24 | +432.2% |
| FY2022 | $0.98 | +87.9% |
| FY2021 | $0.52 | -67.8% |
| FY2020 | $1.62 | +327.6% |
| FY2019 | -$0.71 | -13.1% |
| FY2018 | -$0.63 | +31.1% |
| FY2017 | -$0.92 | +79.8% |
| FY2016 | -$4.54 | -128.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026